PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 1 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7,331 | -43.6% | 19,707 | -11.7% | 0.00% | – |
Q3 2022 | $13,000 | +85.7% | 22,316 | +116.5% | 0.00% | – |
Q2 2022 | $7,000 | -66.7% | 10,307 | -55.5% | 0.00% | -100.0% |
Q1 2022 | $21,000 | +10.5% | 23,175 | +23.0% | 0.00% | 0.0% |
Q4 2021 | $19,000 | -51.3% | 18,842 | +10.2% | 0.00% | 0.0% |
Q2 2021 | $39,000 | – | 17,099 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 40,684 | $83,000 | 0.01% |
Virtu Financial LLC | 45,458 | $92,000 | 0.01% |
Total Clarity Wealth Management, Inc. | 1,500 | $3,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 153,100 | $311,000 | 0.00% |
Cetera Investment Advisers | 30,000 | $61,000 | 0.00% |
UBS Group AG | 6,241 | $13,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 42,137 | $86,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 63 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 53 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |